> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# ANDA for Hydroxyethyl Starch Withdrawn
- URL: https://www.fdaweb.com/anda-for-hydroxyethyl-starch-withdrawn/
- Published: 2021-09-21T12:00:00.000Z
- Updated: 2026-09-14T17:15:33.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5150182

*Federal Register* notice: FDA is withdrawing approval of a B. Braun Medical ANDA for 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection in Excel plastic container after the company requested that it be withdrawn. Hydroxyethyl starch products are approved for treating hypovolemia (low blood volume). To view the notice, click [here](https://public-inspection.federalregister.gov/2021-20511.pdf?ref=fdaweb.com).